Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.36) per share. This is a 12.5 percent decrease over losses of $(0.32) per share from the same period last year.
Stifel Maintains Buy on Six Flags Entertainment, Raises Price Target to $30
Stifel analyst Steve Wieczynski maintains Six Flags Entertainment (NYSE:SIX) with a Buy and raises the price target from $28 to $30.